Cord Blood Banking Market to Hit Nearly $50B

The global cord blood banking market was valued at approximately $27.15 billion in 2024 and is projected to continue its upward trend. This growth is largely fueled by increasing awareness of the therapeutic uses of stem cells found in cord blood. Cord blood contains hematopoietic stem cells, which can develop into various types of blood cells. These cells are currently FDA-approved to treat over 80 diseases, including various cancers like leukemia and lymphoma, as well as blood disorders such as sickle cell anemia and thalassemia. The market is divided between private and public cord blood banks. Private banks store a baby's cord blood for potential future use by the child or family members, for a fee. Public banks accept donations to be used by any matching patient in need, with professional organizations like the American Academy of Pediatrics often encouraging public donation. A significant portion of the market is driven by private banking, which accounted for 46% of the market revenue in 2024. Alongside cord blood, the banking of cord tissue is a rapidly growing segment, as it contains mesenchymal stem cells which are being researched for regenerative medicine applications. Technological advancements are a major factor in the market's expansion. Innovations in cryopreservation and stem cell expansion techniques, which aim to increase the number of stem cells from a single collection, are making cord blood banking more efficient and broadening its potential therapeutic uses. The Asia-Pacific region is expected to see the fastest growth in the coming years. This is attributed to rising awareness, improving healthcare infrastructure, and supportive government initiatives in countries like China and India. Ongoing clinical trials are exploring the use of cord blood stem cells for a wider range of conditions, including neurological disorders like cerebral palsy and autism, as well as cardiovascular diseases. This expanding research is a key indicator of the future growth potential for the cord blood banking industry.